Complex study start-up and site activation.
Feasibility assessment, site selection governance and critical path acceleration for complex oncology, haemato-oncology, rare-disease and novel modality programmes, managing the path from protocol finalisation to first participant in.
Progressed from final protocol to first participant in within eight weeks on an accelerated COVID-19 vaccine programme.
Typical deliverables
feasibility plan, activation forecast, critical path map.
